ReviewMaterials (Basel, Switzerland)2025
Gum Rosin in Medical and Pharmaceutical Applications: From Conventional Uses to Modern Advancements.
Review in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gum rosin and its derivatives have been used traditionally in coatings and adhesives and are now increasingly applied in diverse medical and pharmaceutical fields. Owing to its film-forming ability, hydrophobic nature, biocompatibility, and ease of chemical modification, gum rosin has emerged as a promising excipient for controlled drug release, targeted drug delivery, and other biomedical applications. This review summarizes the evolution of gum rosin applications, from its conventional roles to its modern utilization in nanocarriers, transdermal systems, and other advanced drug delivery platforms. In addition, we discuss the challenges related to allergenicity, brittleness, and excessive hydrophobicity and propose strategies (such as chemical modification and polymer blending) to overcome these issues. This review provides a reference framework for researchers developing new rosin-based materials in pharmaceutical sciences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.